We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SVRA market cap is 413.08M. The company's latest EPS is USD -0.5547 and P/E is -4.31.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.48M | -23.19M | -26.36M | -31.17M | -28.44M |
| Net Income | -20.35M | -22.24M | -24.25M | -29.04M | -26.64M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 257k | 0 | 0 | 0 | 0 |
| Operating Income | -49.3M | -41.48M | -38.84M | -60.01M | -103.2M |
| Net Income | -49.62M | -43.01M | -38.15M | -54.7M | -95.88M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 158.3M | 139.67M | 238.82M | 212.88M | 189.32M |
| Total Liabilities | 36.43M | 37.94M | 39.47M | 41.43M | 41.47M |
| Total Equity | 121.86M | 101.73M | 199.35M | 171.45M | 147.85M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 97.75M | 176.6M | 139.78M | 177.56M | 212.88M |
| Total Liabilities | 33.36M | 32.1M | 32M | 37.19M | 41.43M |
| Total Equity | 64.38M | 144.5M | 107.78M | 140.37M | 171.45M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.64M | -43.14M | -65.81M | -89.09M | -27.19M |
| Investing | 10.79M | 40.33M | -57.84M | -39.94M | 29.33M |
| Financing | 49k | 104k | 118.42M | 117.58M | 2.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -39.84M | -40.08M | -34.55M | -51.06M | -89.09M |
| Investing | 9.05M | -69.46M | 52.65M | -57.12M | -39.94M |
| Financing | 3.69M | 120.81M | 87k | 82.78M | 117.58M |
| Market Cap | 413.08M |
| Price to Earnings Ratio | -4.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 27.31 |
| Price to Book Ratio | 2.41 |
| Dividend Yield | - |
| Shares Outstanding | 172.84M |
| Average Volume (1 week) | 1.33M |
| Average Volume (1 Month) | 1.44M |
| 52 Week Change | -51.12% |
| 52 Week High | 5.025 |
| 52 Week Low | 1.89 |
| Spread (Intraday) | 0.04 (1.67%) |
| Company Name | Savara Inc |
| Address |
corporation service company wilmington, delaware 19808 |
| Website | https://savarapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
